
PGIM India Healthcare Fund Direct Growth is a Equity mutual fund scheme launched on 06 Dec 2024. The current NAV stands at ₹12.9300 as of 12 Nov 2026. From the funds total AUM, its top holdings include Sun Pharmaceutical at 11.34%, Divis Laboratories at 10.01%, J B Chemicals and Pharmaceuticals at 6.53%, Aster DM Healthcare at 6.44%, Rubicon Research at 5.97%
Scheme Overview
- Inception Date : 06 Dec 2024
- AUM : ₹142.13 Cr
- 1Y Returns (CAGR) : 26.92%
- Expense Ratio : 0.96%
- Min. SIP : ₹1,000
- Min. Lumpsum : ₹5,000
Returns Calculator
basis annualised returns
Investment Type
SIP Amount
Investment Period
1Y
₹ 6.10 L
3.50%
₹ 6.27 L
8.00%
₹ 6.95 L
26.92%
Total Investment
₹ 6,00,000
Returns
₹ 95,107 (26.92%)
Maturity Value
₹ 6,95,107
Disclaimer: Fixed deposits offer guaranteed returns. Mutual fund investments carry market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns.
Direct vs Regular Returns
Sorry, No Data Available at this Moment!
Returns vs Category
Sorry, No Data Available at this Moment!
*The above returns are absolute
Returns Vs Nifty 50
Historical Returns
Sorry, No Data Available at this Moment!
Start SIP with as Low as ₹100.
Historical NAV
Sorry, No Data Available at this Moment!
Asset Allocation
AUM
₹ 142.13 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Asset Allocation
AUM
₹142.13 Cr
Cash Holding
-
Equity
-
Cash
-
Debt
-
Other
-
Sector Holdings
as of 31 May 2026
| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Healthcare | 92.28% | ||
| Basic Materials | 3.10% | ||
| Financial Services | 2.52% | ||
| Other | 2.10% |
Stock Holdings
as of 31 May 2026
| Name | Allocation | Weightage |
|---|---|---|
![]() S Sun Pharmaceutical | 11.34% | |
![]() D Divis Laboratories | 10.01% | |
![]() J J B Chemicals and Pharmaceuticals | 6.53% | |
![]() A Aster DM Healthcare | 6.44% | |
R Rubicon Research | 5.97% | |
![]() M Mankind Pharma | 5.24% | |
![]() M Max Healthcare Institute | 4.97% | |
![]() A Ajanta Pharma | 4.68% | |
![]() K Krishna Institute of Medical Sciences | 4.15% | |
![]() D Dr. Lal Path Labs | 3.27% | |
![]() N Neuland Laboratories | 3.17% | |
![]() N Navin Fluorine International | 3.10% | |
![]() A Abbott | 2.92% | |
![]() D Dr Reddys Laboratories | 2.73% | |
![]() T Torrent Pharmaceuticals | 2.66% | |
![]() S Sai Life Sciences | 2.64% | |
![]() A Anthem Biosciences | 2.19% | |
![]() J Jupiter Life Line Hospital | 2.08% | |
![]() C Clearing Corporation Of India Ltd. | 1.92% | |
![]() G Global Health | 1.81% | |
![]() C Cipla | 1.63% | |
![]() F Fortis Healthcare | 1.47% | |
![]() P PB FinTech | 1.37% | |
![]() L Lupin | 1.35% | |
![]() P Pfizer | 1.32% | |
![]() I ICICI Lombard General Insurance | 1.15% | |
![]() D Dr. Agarwal's Health Care | 1.06% | |
![]() O Orchid Pharma | 0.85% | |
![]() L Lenskart Solutions | 0.74% | |
![]() S Sagility | 0.53% | |
![]() D Dr. Agrawals Eye Hospital | 0.52% | |
![]() N Net Receivables / (Payables) | 0.18% |
Fund Comparison
Fund Details
52W High NAV
₹ 12.8700
Min. SIP Amount
₹ 1,000.00
Min. Lumpsum Amount
₹ 5,000.00
AUM (in Cr.)
₹ 142.13
Expense Ratio
0.96%
Lock-in Period
No Lock in Period
52W Low NAV
₹ 9.4200
Inception Date
06 Dec 2024
Fund Age
1 Yrs
Benchmark
BSE Healthcare TRI
Scheme Type
Open Ended
Stamp Duty
0.005% (from July 1st 2020)
Exit Load
- Exit load of 0.50%, if redeemed within 90 days.
Tax Implication
- If you redeem within 1 year, STCG are taxed at 20%; If you redeem after 1 year, and returns exceed ₹1.25 Lakhs in a financial year, LTCG are taxed at 12.5%
Fund Managers
| Name | Qualification |
|---|---|
| Puneet Pal | MBA(finance)from SIBM,Pune. |
| Vivek Sharma | B.E (Electronic), PGDBM - Finance |
| Anandha Padmanabhan Anjen | B Com, ACA, CFA, FRM |
| Utsav Mehta | B.Com., CFA |
Fund Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns
Risk-O-Meter
Investors understand that their principal will be at
Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
PGIM India Mutual Fund
No. of Schemes
23
Total AUM
₹ 23,923.08 Cr
Contact Details
4th Floor, C Wing, Laxmi Towers,Bandra Kurla Complex,Bandra (East), Mumbai - 400 051
Contact Details
4th Floor, C Wing, Laxmi Towers,Bandra Kurla Complex,Bandra (East), Mumbai - 400 051
FAQs
When was PGIM India Healthcare Fund launched?
What is the current NAV of PGIM India Healthcare Fund?
What is the AUM of PGIM India Healthcare Fund?
What is the rate of return of PGIM India Healthcare Fund?
- In the past 1Y: 26.92%
- In the past 3Y: 0.00%
- In the past 5Y: 0.00%
What is the expense ratio of PGIM India Healthcare Fund?
What is exit load of PGIM India Healthcare Fund?
What is the portfolio of PGIM India Healthcare Fund?
- Sun Pharmaceutical: 11.34%
- Divis Laboratories: 10.01%
- J B Chemicals and Pharmaceuticals: 6.53%
- Aster DM Healthcare: 6.44%
- Rubicon Research: 5.97%
Top 3 sectoral holdings include:
- Healthcare: 92.28%
- Basic Materials: 3.10%
- Financial Services: 2.52%
How risky is investing in PGIM India Healthcare Fund?
Who is the fund manager PGIM India Healthcare Fund?
What is the minimum investment required in PGIM India Healthcare Fund?
How to invest in PGIM India Healthcare Fund directly?
- Open Demat Account on Dhan if you don't have one.
- Analyze the fund performance.
- Invest via SIP or Lumpsum.

Invest in
Pay 0% Commission!
+91
Or Scan the QR Code to download the Dhan App
































